187 related articles for article (PubMed ID: 30390385)
21. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes.
Scott EM; Bilous RW; Kautzky-Willer A
Diabetes Technol Ther; 2018 Mar; 20(3):180-188. PubMed ID: 29470094
[TBL] [Abstract][Full Text] [Related]
22. Reduced Rate of Acute Diabetes Events with Flash Glucose Monitoring Is Sustained for 2 Years After Initiation: Extended Outcomes from the RELIEF Study.
Riveline JP; Roussel R; Vicaut E; de Pouvourville G; Detournay B; Emery C; Levrat-Guillen F; Guerci B
Diabetes Technol Ther; 2022 Sep; 24(9):611-618. PubMed ID: 35604792
[No Abstract] [Full Text] [Related]
23. Comparison of accuracy between flash glucose monitoring and continuous glucose monitoring in patients with type 2 diabetes mellitus undergoing hemodialysis.
Matoba K; Hayashi A; Shimizu N; Moriguchi I; Kobayashi N; Shichiri M
J Diabetes Complications; 2020 Nov; 34(11):107680. PubMed ID: 32736927
[TBL] [Abstract][Full Text] [Related]
24. Unrecognized hypo- and hyperglycemia in well-controlled patients with type 2 diabetes mellitus: the results of continuous glucose monitoring.
Hay LC; Wilmshurst EG; Fulcher G
Diabetes Technol Ther; 2003; 5(1):19-26. PubMed ID: 12725703
[TBL] [Abstract][Full Text] [Related]
25. Flash glucose monitoring in type 1 diabetes: A comparison with self-monitoring blood glucose.
Babaya N; Noso S; Hiromine Y; Taketomo Y; Niwano F; Yoshida S; Yasutake S; Kawabata Y; Ikegami H
J Diabetes Investig; 2020 Sep; 11(5):1222-1229. PubMed ID: 32027468
[TBL] [Abstract][Full Text] [Related]
26. Impact of the FreeStyle Libre flash glucose monitoring system on diabetes- self-management practices and glycemic control among patients with type 2 diabetes in Saudi Arabia: A prospective study.
Al Hayek A; Robert AA; Al Dawish M
Diabetes Metab Syndr; 2021; 15(2):557-563. PubMed ID: 33689937
[TBL] [Abstract][Full Text] [Related]
27. The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study.
Bosi E; Gregori G; Cruciani C; Irace C; Pozzilli P; Buzzetti R
Diabetes Res Clin Pract; 2022 Jan; 183():109172. PubMed ID: 34883185
[TBL] [Abstract][Full Text] [Related]
28. Flash Continuous Glucose Monitoring (FreeStyle Libre 14-Day System) for Self-Management of Diabetes Mellitus.
Choi HYJ
Am Fam Physician; 2021 Jun; 103(11):688-690. PubMed ID: 34060782
[No Abstract] [Full Text] [Related]
29. Real-time CGM Is Superior to Flash Glucose Monitoring for Glucose Control in Type 1 Diabetes: The CORRIDA Randomized Controlled Trial.
Hásková A; Radovnická L; Petruželková L; Parkin CG; Grunberger G; Horová E; Navrátilová V; Kádě O; Matoulek M; Prázný M; Šoupal J
Diabetes Care; 2020 Nov; 43(11):2744-2750. PubMed ID: 32859607
[TBL] [Abstract][Full Text] [Related]
30. Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study).
Elhadd T; Bashir M; Baager KA; Ali HA; Almohannadi DHS; Dabbous Z; Malik RA; Abou-Samra AB;
Diabetes Res Clin Pract; 2021 Feb; 172():108589. PubMed ID: 33316309
[TBL] [Abstract][Full Text] [Related]
31. Effect of 6 months' flash glucose monitoring in adolescents and young adults with type 1 diabetes and suboptimal glycaemic control: managing diabetes in a 'flash' randomised controlled trial protocol.
Boucher SE; Gray AR; de Bock M; Wiltshire EJ; Galland BC; Tomlinson PA; Rayns J; MacKenzie KE; Wheeler BJ
BMC Endocr Disord; 2019 May; 19(1):50. PubMed ID: 31109342
[TBL] [Abstract][Full Text] [Related]
32. Reduction in HbA1c using professional flash glucose monitoring in insulin-treated type 2 diabetes patients managed in primary and secondary care settings: A pilot, multicentre, randomised controlled trial.
Ajjan RA; Jackson N; Thomson SA
Diab Vasc Dis Res; 2019 Jul; 16(4):385-395. PubMed ID: 31271312
[TBL] [Abstract][Full Text] [Related]
33. Numerical and clinical precision in hypoglycemia of the intermittent FreeStyle Libre glucose monitoring through an NFC-Bluetooth transmitter associated with the xDrip+ algorithm in diabetic patients under insulin therapy.
Gómez Medina AM; Henao Carrillo DC; León Vargas FM; Jojoa Jojoa RI; Quijano Naranjo JE; Rondón-Sepulveda MA; García Jaramillo MA; Muñoz Velandia OM
Endocrinol Diabetes Nutr (Engl Ed); 2023 Mar; 70(3):212-219. PubMed ID: 36967328
[TBL] [Abstract][Full Text] [Related]
34. Critical discrepancy in blood glucose control levels evaluated by glycated albumin and estimated hemoglobin A1c levels determined from a flash continuous glucose monitoring system in patients with type 2 diabetes on hemodialysis.
Ushigome E; Matsusaki S; Watanabe N; Hashimoto T; Nakamura N; Fukui M
J Diabetes Investig; 2020 Nov; 11(6):1570-1574. PubMed ID: 32356596
[TBL] [Abstract][Full Text] [Related]
35. Effect of switch from flash glucose monitoring to flash glucose monitoring with real-time alarms on hypoglycaemia in people with type 1 diabetes mellitus.
Gutiérrez-Pastor A; Quesada JA; Soler-Martínez MM; Carratalá Munuera C; Pomares-Gómez FJ
Prim Care Diabetes; 2024 Jun; 18(3):333-339. PubMed ID: 38677966
[TBL] [Abstract][Full Text] [Related]
36. Risk Factor Analysis for Type 2 Diabetes Patients About Hypoglycemia Using Continuous Glucose Monitoring: Results from a Prospective Observational Study.
Uemura F; Okada Y; Mita T; Torimoto K; Wakasugi S; Katakami N; Yoshii H; Matsushita K; Nishida K; Inokuchi N; Tanaka Y; Gosho M; Shimomura I; Watada H
Diabetes Technol Ther; 2022 Jun; 24(6):435-445. PubMed ID: 35049378
[No Abstract] [Full Text] [Related]
37. Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy.
Sola-Gazagnes A; Faucher P; Jacqueminet S; Ciangura C; Dubois-Laforgue D; Mosnier-Pudar H; Roussel R; Larger E
Diabetes Metab; 2020 Apr; 46(2):158-163. PubMed ID: 31415813
[TBL] [Abstract][Full Text] [Related]
38. The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care.
Alawadi F; Rashid F; Bashier A; Abdelgadir E; Al Saeed M; Abuelkheir S; Khalifa A; Al Sayyah F; Bachet F; Elsayed M; Abdallah K; Hassanein M
Diabetes Res Clin Pract; 2019 May; 151():305-312. PubMed ID: 30880094
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of insulin glargine 300 U/mL vs insulin degludec in patients with type 2 diabetes: A randomized, open-label, cross-over study using continuous glucose monitoring profiles.
Kawaguchi Y; Sawa J; Sakuma N; Kumeda Y
J Diabetes Investig; 2019 Mar; 10(2):343-351. PubMed ID: 29947060
[TBL] [Abstract][Full Text] [Related]
40. Comparison of insulin glargine 300 U/mL and insulin degludec using flash glucose monitoring: A randomized cross-over study.
Yamabe M; Kuroda M; Hirosawa Y; Kamino H; Ohno H; Yoneda M
J Diabetes Investig; 2019 Mar; 10(2):352-357. PubMed ID: 29989335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
